Biognosys secures $5 Million in C round

Bio-Technopark based startup Biognosys offering proteomics solutions has raised $5 million from new and existing investors in an extended series C round. The funds will be used to bring proteomics to the broader life science research market. Biognosys is a proteomics company offering innovative services and products for highly multiplexed protein...

read more

Zurich holds all the biotechnology aces

Zurich – The greater Zurich region has all the aces needed for a successful biotechnology centre, says Roger Nitsch, president of the Schlieren-based company Neurimmune. It has the best and the brightest – and the right infrastructure in the shape of the Bio-Technopark Schlieren-Zurich. The greater Zurich region is well on...

read more